Evidence map›Paper›PMID 31835352›Full record

ReviewCells2019

The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases.

Haojie Wang, Yumei Liu, Dongmei Wang, Yaolu Xu, Ruiqi Dong, Yuxiang Yang, Qiongxia Lv, Xiaoguang Chen, Ziqiang Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 276 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Gut microbes · 2025
    Article
  18. Article
  19. Article
  20. Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Haojie WangCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Yumei LiuCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Dongmei WangCollege of Medical, Henan University of Science and Technology, Luoyang 471000, China.
Yaolu XuCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Ruiqi DongCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Yuxiang YangCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Qiongxia LvCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Xiaoguang ChenCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Ziqiang ZhangCollege of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471000, China.
Henan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy, originally found in liver experiments, is a cellular process that degrades damaged organelle or protein aggregation. This process frees cells from various stress states is a cell survival mechanism under stress stimulation. It is now known that dysregulation of autophagy can cause many liver diseases. Therefore, how to properly regulate autophagy is the key to the treatment of liver injury. mechanistic target of rapamycin (mTOR)is the core hub regulating autophagy, which is subject to different upstream signaling pathways to regulate autophagy. This review summarizes three upstream pathways of mTOR: the phosphoinositide 3-kinase (PI3K)/protein kinase (AKT) signaling pathway, the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, and the rat sarcoma (Ras)/rapidly accelerated fibrosarcoma (Raf)/mitogen-extracellular activated protein kinase kinase (MEK)/ extracellular-signal-regulated kinase (ERK) signaling pathway, specifically explored their role in liver fibrosis, hepatitis B, non-alcoholic fatty liver, liver cancer, hepatic ischemia reperfusion and other liver diseases through the regulation of mTOR-mediated autophagy. Moreover, we also analyzed the crosstalk between these three pathways, aiming to find new targets for the treatment of human liver disease based on autophagy.

Indexed as

AnimalsAutophagyExtracellular Signal-Regulated MAP KinasesHumansLiver DiseasesMitogen-Activated Protein Kinase KinasesPhosphatidylinositol 3-KinasesSignal TransductionExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinase KinasesPhosphatidylinositol 3-KinasesAKTAMPKautophagyERKliver diseasesMEKmTORPI3KRafRas

Identifiers

PMID31835352
PMCPMC6953127
OpenAlexW2992985193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.